A phase II trial of neo-adjuvant docetaxel (D) and estramustine (E) in patients with high risk/locally advanced prostate cancer
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4753-4753
◽
Keyword(s):
Phase Ii
◽
1996 ◽
Vol 36
(3)
◽
pp. 673-680
◽
1994 ◽
Vol 29
(3)
◽
pp. 611-616
◽
1992 ◽
Vol 22
(3)
◽
pp. 565-568
◽